reference/17668973

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17668973

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	2616
issn	0340-7004 1432-0851
issueIdentifier	9
pageRange	2601-2616
publicationName	Cancer immunology, immunotherapy : CII
startingPage	2601
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_048945057022a969112cdf3676a48402 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7f0fe366f3a9fb00cbdf88cfef863bcc
bibliographicCitation	Liu S, Zhang C, Wang B, Zhang H, Qin G, Li C, Cao L, Gao Q, Ping Y, Zhang K, Lian J, Zhao Q, Wang D, Zhang Z, Zhao X, Yang L, Huang L, Yang B, Zhang Y. Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling. Cancer Immunology, Immunotherapy. 2021 Feb 12;70(9):2601–16. doi: 10.1007/s00262-021-02872-0.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba8718c8f325906de1700b255d5545b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b888418c3a3e793fd8f49f4d39223006 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca7319d4b8f6ea9d0a974e733631ff0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9861-4681 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_892f25429ad51282805a84c5bfec081f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed8503654618e654ae316dc3759bd3b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c3da504de209fe69dec81452f9bb139c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5ab8a5b4d0b10c8d536e36599fc7915 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18c23d3a678b40d892c13272020e355a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60314c9376bf62fdc9cbd67dda6da1df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d55d674af3f09d7dfa34782d65413f06 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c48b6f831e3ed7ee3087e1b149506068 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76b2b7092602b09e2d05e88243cea817 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e95ba4b12da643d859fd1d8febb2994f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_024f6c278c00fbe664616687124465e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3c06f184b535c16b6bb4fcc0e4c3e81 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fd67b999e4deb02fb66f13d52c02157 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_629ac1a1aea07fe63fa03dd4b35ba75f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed133f313208c712d45dd5158f85e655
date	2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8360896 https://doi.org/10.1007/s00262-021-02872-0 https://pubmed.ncbi.nlm.nih.gov/33576874
isPartOf	https://portal.issn.org/resource/ISSN/0340-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2781 https://portal.issn.org/resource/ISSN/1432-0851
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling
discusses	http://id.nlm.nih.gov/mesh/M0024757 http://id.nlm.nih.gov/mesh/M0024747 http://id.nlm.nih.gov/mesh/M0229085 http://id.nlm.nih.gov/mesh/M0024272 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0488127 http://id.nlm.nih.gov/mesh/M0024955 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0477916
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2361 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95858a7883c26280557b4db19d204c39 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d7b2eac3b0ae5d9f772a801186d6c71 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_add6d0d2cdb9bd9c4e0326cf16d4e20c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 62.